Cargando…

Minimally invasive prostate cancer detection test using FISH probes

PURPOSE: The ability to test for and detect prostate cancer with minimal invasiveness has the potential to reduce unnecessary prostate biopsies. This study was conducted as part of a clinical investigation for the development of an OligoFISH(®) probe panel for more accurate detection of prostate can...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinawi-Aljundi, Rima, Knuth, Shannon T, Gildea, Michael, Khal, Joshua, Hafron, Jason, Kernen, Kenneth, Di Loreto, Robert, Aurich-Costa, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968981/
https://www.ncbi.nlm.nih.gov/pubmed/27556017
http://dx.doi.org/10.2147/RRU.S109450
_version_ 1782445730059780096
author Tinawi-Aljundi, Rima
Knuth, Shannon T
Gildea, Michael
Khal, Joshua
Hafron, Jason
Kernen, Kenneth
Di Loreto, Robert
Aurich-Costa, Joan
author_facet Tinawi-Aljundi, Rima
Knuth, Shannon T
Gildea, Michael
Khal, Joshua
Hafron, Jason
Kernen, Kenneth
Di Loreto, Robert
Aurich-Costa, Joan
author_sort Tinawi-Aljundi, Rima
collection PubMed
description PURPOSE: The ability to test for and detect prostate cancer with minimal invasiveness has the potential to reduce unnecessary prostate biopsies. This study was conducted as part of a clinical investigation for the development of an OligoFISH(®) probe panel for more accurate detection of prostate cancer. MATERIALS AND METHODS: One hundred eligible male patients undergoing transrectal ultrasound biopsies were enrolled in the study. After undergoing digital rectal examination with pressure, voided urine was collected in sufficient volume to prepare at least two slides using ThinPrep. Probe panels were tested on the slides, and 500 cells were scored when possible. From the 100 patients recruited, 85 had more than 300 cells scored and were included in the clinical performance calculations. RESULTS: Chromosomes Y, 7, 10, 20, 6, 8, 16, and 18 were polysomic in most prostate carcinoma cases. Of these eight chromosomes, chromosomes 7, 16, 18, and 20 were identified as having the highest clinical performance as a fluorescence in situ hybridization test and used to manufacture the fluorescence in situ hybridization probe panels. The OligoFISH(®) probes performed with 100% analytical specificity. When the OligoFISH(®) probes were compared with the biopsy results for each individual, the test results highly correlated with positive and negative prostate biopsy pathology findings, supporting their high specificity and accuracy. Probes for chromosomes 7, 16, 18, and 20 showed in the receiver operator characteristics analysis an area under the curve of 0.83, with an accuracy of 81% in predicting the biopsy result. CONCLUSION: This investigation demonstrates the ease of use with high specificity, high predictive value, and accuracy in identifying prostate cancer in voided urine after digital rectal examination with pressure. The test is likely to have positive impact on clinical practice and advance approaches to the detection of prostate cancer. Further evaluation is warranted.
format Online
Article
Text
id pubmed-4968981
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-49689812016-08-23 Minimally invasive prostate cancer detection test using FISH probes Tinawi-Aljundi, Rima Knuth, Shannon T Gildea, Michael Khal, Joshua Hafron, Jason Kernen, Kenneth Di Loreto, Robert Aurich-Costa, Joan Res Rep Urol Original Research PURPOSE: The ability to test for and detect prostate cancer with minimal invasiveness has the potential to reduce unnecessary prostate biopsies. This study was conducted as part of a clinical investigation for the development of an OligoFISH(®) probe panel for more accurate detection of prostate cancer. MATERIALS AND METHODS: One hundred eligible male patients undergoing transrectal ultrasound biopsies were enrolled in the study. After undergoing digital rectal examination with pressure, voided urine was collected in sufficient volume to prepare at least two slides using ThinPrep. Probe panels were tested on the slides, and 500 cells were scored when possible. From the 100 patients recruited, 85 had more than 300 cells scored and were included in the clinical performance calculations. RESULTS: Chromosomes Y, 7, 10, 20, 6, 8, 16, and 18 were polysomic in most prostate carcinoma cases. Of these eight chromosomes, chromosomes 7, 16, 18, and 20 were identified as having the highest clinical performance as a fluorescence in situ hybridization test and used to manufacture the fluorescence in situ hybridization probe panels. The OligoFISH(®) probes performed with 100% analytical specificity. When the OligoFISH(®) probes were compared with the biopsy results for each individual, the test results highly correlated with positive and negative prostate biopsy pathology findings, supporting their high specificity and accuracy. Probes for chromosomes 7, 16, 18, and 20 showed in the receiver operator characteristics analysis an area under the curve of 0.83, with an accuracy of 81% in predicting the biopsy result. CONCLUSION: This investigation demonstrates the ease of use with high specificity, high predictive value, and accuracy in identifying prostate cancer in voided urine after digital rectal examination with pressure. The test is likely to have positive impact on clinical practice and advance approaches to the detection of prostate cancer. Further evaluation is warranted. Dove Medical Press 2016-07-27 /pmc/articles/PMC4968981/ /pubmed/27556017 http://dx.doi.org/10.2147/RRU.S109450 Text en © 2016 Tinawi-Aljundi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tinawi-Aljundi, Rima
Knuth, Shannon T
Gildea, Michael
Khal, Joshua
Hafron, Jason
Kernen, Kenneth
Di Loreto, Robert
Aurich-Costa, Joan
Minimally invasive prostate cancer detection test using FISH probes
title Minimally invasive prostate cancer detection test using FISH probes
title_full Minimally invasive prostate cancer detection test using FISH probes
title_fullStr Minimally invasive prostate cancer detection test using FISH probes
title_full_unstemmed Minimally invasive prostate cancer detection test using FISH probes
title_short Minimally invasive prostate cancer detection test using FISH probes
title_sort minimally invasive prostate cancer detection test using fish probes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968981/
https://www.ncbi.nlm.nih.gov/pubmed/27556017
http://dx.doi.org/10.2147/RRU.S109450
work_keys_str_mv AT tinawialjundirima minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT knuthshannont minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT gildeamichael minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT khaljoshua minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT hafronjason minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT kernenkenneth minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT diloretorobert minimallyinvasiveprostatecancerdetectiontestusingfishprobes
AT aurichcostajoan minimallyinvasiveprostatecancerdetectiontestusingfishprobes